Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy

Published:2022-06 Issue:6 Volume:20 Page:1290-1300
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Mast Alan E.^ORCID,Ruf Wolfram^ORCID

Funder

Novo Nordisk

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15697

Reference113 articles.

1. Purification and characterization of the lipoprotein‐associated coagulation inhibitor from human plasma;Novotny;J Biol Chem,1989

2. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor;Novotny;Blood,1988

3. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets;Maroney;Blood,2007

4. Major reservoir for heparin‐releasable TFPIalpha (tissue factor pathway inhibitor alpha) is extracellular matrix;Peterson;Arterioscler Thromb Vasc Biol,2021

5. Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice;Maroney;J Thromb Haemost,2009

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis;Intensive Care Medicine;2024-09-02

2. Targeting tissue factor pathway inhibitor with concizumab to improve hemostasis in patients with Glanzmann thrombasthenia: an in vitro study;Journal of Thrombosis and Haemostasis;2024-09

3. Haemostatic Proteins as Markers of Disease Progression and Prognosis in Breast Cancer;2024-07-12

4. Endothelial cell dysfunction and targeted therapeutic drugs in sepsis;Heliyon;2024-07

5. Anticoagulation reversal (vitamin K, prothrombin complex concentrates, idarucizumab, andexanet‐α, protamine);British Journal of Clinical Pharmacology;2024-06-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3